![diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2](https://www.ncbi.nlm.nih.gov/books/NBK559432/bin/db202021f4.jpg)
diabetes glp-1 vs sglt2
Shipping Estimate
diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2
USD20.52
USD62.52
Pay in 4 interest-free payments of $5.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
![diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13300-019-00680-5/MediaObjects/13300_2019_680_Fig1_HTML.png)
![diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2](https://www.bmj.com/content/bmj/385/bmj-2023-078242/F4.large.jpg)
![diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-023-05975-8/MediaObjects/125_2023_5975_Figa_HTML.png)
![diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2](https://e-dmj.org/upload/thumbnails/dmj-2025-0220f1.jpg)
![diabetes glp-1 vs sglt2 FIGURE 4, [Choosing glucose-lowering medication for patients...]. - Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 in Primary Care Cardiorenal Protection: Potential of SGLT2](https://www.mct2d.org/_next/image?url=https%3A%2F%2Fimages.ctfassets.net%2F1p0t6jhbvwk9%2F403XqE9DV4du6c5TF4rOoH%2F8fc47c59d4eb11bd1aca7b5a076b2d41%2FScreenshot_2026-06-02_at_12.19.24%25C3%25A2__PM.png&w=3840&q=75)
